Inmed pharmaceuticals (inm): acquiring baymedica

London, uk / accesswire / september 20, 2021 / inmed has announced that it has entered into a definitive agreement to acquire baymedica, a private us-based company that is focusing on the manufacture and commercialization of rare cannabinoids. this is an all-stock transaction in which inmed will issue 1.78m shares to baymedica's equity and convertible debt holders.
INM Ratings Summary
INM Quant Ranking